Is Coya Therapeutics, Inc. (COYA) a Buy, Sell, or Hold?
Coya Therapeutics, Inc.
NASDAQ:COYA
$4.84 USD
-$0.03 (-0.62%)
- Volume
- 256.53K
- Average Volume
- 185.58K
- Market Capitalization
- $88.13M
- P/E Ratio
- -4.21
- Dividend Yield
- 0.00%
- Price Target
- $12.00
- Year High
- $7.75
- Year Low
- $3.71
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $15.02
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
25
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
1
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 17557
COYA Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
COYA Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Pavao Mark H | director | 2026-04-09 | A-Award | 4.53 | 2026-04-09 |
| Pavao Mark H | 2026-04-01 | 0 | 2026-04-09 | ||
| SNYDER DAVID S | officer: Chief Financial Officer | 2026-01-22 | A-Award | 4.73 | 2026-01-26 |
| Grossman Fred | officer: Chief Medical Officer | 2026-01-22 | A-Award | 4.73 | 2026-01-26 |
| Berman Howard | director, officer: Executive Chairman | 2026-01-22 | A-Award | 4.73 | 2026-01-26 |
| Swaminathan Arun | director, officer: Chief Executive Officer | 2026-01-22 | A-Award | 4.73 | 2026-01-26 |
| Villalobos Anabella | director | 2026-01-02 | A-Award | 5.65 | 2026-01-06 |
| GOLDSTEIN DOV A MD | director | 2026-01-02 | A-Award | 5.65 | 2026-01-06 |
| Weinand Dieter | director | 2026-01-02 | A-Award | 5.65 | 2026-01-06 |
| ROSS WILBUR L JR | director | 2026-01-02 | A-Award | 5.65 | 2026-01-06 |
| Lee Ann | director | 2026-01-02 | A-Award | 5.65 | 2026-01-06 |
| GOLDSTEIN DOV A MD | director | 2025-08-18 | M-Exempt | 1.09 | 2025-08-19 |
| GOLDSTEIN DOV A MD | director | 2025-08-18 | M-Exempt | 1.09 | 2025-08-19 |
| Lee Ann | director | 2025-02-25 | A-Award | 5.97 | 2025-02-25 |
| Villalobos Anabella | director | 2025-02-25 | A-Award | 5.97 | 2025-02-25 |
| GOLDSTEIN DOV A MD | director | 2025-02-25 | A-Award | 5.97 | 2025-02-25 |
| Weinand Dieter | director | 2025-02-25 | A-Award | 5.97 | 2025-02-25 |
| ROSS WILBUR L JR | director | 2025-02-25 | A-Award | 5.97 | 2025-02-25 |
| SNYDER DAVID S | officer: Chief Financial Officer | 2025-01-09 | A-Award | 6.07 | 2025-01-13 |
| Swaminathan Arun | director, officer: Chief Executive Officer | 2025-01-09 | A-Award | 6.07 | 2025-01-13 |
| Grossman Fred | officer: Chief Medical Officer | 2025-01-09 | A-Award | 6.07 | 2025-01-13 |
| Berman Howard | director | 2025-01-09 | A-Award | 6.07 | 2025-01-13 |
| GOLDSTEIN DOV A MD | director | 2025-01-01 | A-Award | 5.73 | 2025-01-03 |
| ROSS WILBUR L JR | director | 2025-01-01 | A-Award | 5.73 | 2025-01-03 |
| Lee Ann | director | 2025-01-01 | A-Award | 5.73 | 2025-01-03 |
| Villalobos Anabella | director | 2025-01-01 | A-Award | 5.73 | 2025-01-03 |
| Weinand Dieter | director | 2025-01-01 | A-Award | 5.73 | 2025-01-03 |
| SNYDER DAVID S | officer: Chief Financial Officer | 2024-11-14 | P-Purchase | 7.1858 | 2024-11-14 |
| Swaminathan Arun | director, officer: Chief Executive Officer | 2024-11-13 | P-Purchase | 7.3594 | 2024-11-13 |
| Grossman Fred | officer: Chief Medical Officer | 2024-11-11 | P-Purchase | 7.37 | 2024-11-12 |
| Swaminathan Arun | director, officer: Chief Executive Officer | 2024-11-11 | P-Purchase | 7.3378 | 2024-11-12 |
| Swaminathan Arun | director | 2024-08-19 | 4.05 | 2024-08-20 | |
| Swaminathan Arun | director | 2024-08-19 | 8.15 | 2024-08-20 | |
| Swaminathan Arun | director | 2024-08-19 | 5.9 | 2024-08-20 | |
| SNYDER DAVID S | officer: Chief Financial Officer | 2024-06-03 | A-Award | 8.15 | 2024-06-05 |
| Berman Howard | director, officer: Chief Executive Officer | 2024-06-03 | A-Award | 8.15 | 2024-06-05 |
| Grossman Fred | officer: Chief Medical Officer | 2024-06-03 | A-Award | 8.15 | 2024-06-05 |
| Lee Ann | director | 2023-08-22 | P-Purchase | 3.62 | 2024-03-05 |
| Grossman Fred | officer: Chief Medical Officer | 2024-01-31 | A-Award | 5.9 | 2024-02-02 |
| Grossman Fred | officer: Chief Medical Officer | 2024-01-31 | A-Award | 5.9 | 2024-02-02 |
| SNYDER DAVID S | officer: Chief Financial Officer | 2024-01-31 | A-Award | 5.9 | 2024-02-02 |
| Berman Howard | director, officer: Chief Executive Officer | 2024-01-31 | A-Award | 5.9 | 2024-02-02 |
| Weinand Dieter | director | 2024-01-01 | A-Award | 7.41 | 2024-01-19 |
| Garren Hideki | director | 2024-01-01 | A-Award | 7.41 | 2024-01-19 |
| GOLDSTEIN DOV A MD | director | 2024-01-01 | A-Award | 7.41 | 2024-01-19 |
| Lee Ann | director | 2024-01-01 | A-Award | 7.41 | 2024-01-19 |
| Villalobos Anabella | director | 2024-01-01 | A-Award | 7.41 | 2024-01-19 |
| ROSS WILBUR L JR | director | 2024-01-02 | A-Award | 6.97 | 2024-01-04 |
| ROSS WILBUR L JR | director | 2023-12-19 | 0 | 2023-12-29 | |
| Weinand Dieter | director | 2023-08-18 | A-Award | 3.43 | 2023-08-21 |
| Weinand Dieter | director: | 2023-08-18 | 0 | 2023-08-21 | |
| Grossman Fred | officer: Chief Medical Officer | 2023-07-17 | A-Award | 4.25 | 2023-07-19 |
| Grossman Fred | officer | 2023-07-17 | 0 | 2023-07-19 | |
| Berman Howard | director, officer: Chief Executive Officer | 2023-02-27 | A-Award | 3.85 | 2023-03-01 |
| Hepner Adrian | officer: Chief Medical Officer | 2023-02-27 | A-Award | 3.85 | 2023-03-01 |
| SNYDER DAVID S | officer: Chief Financial Officer | 2023-02-27 | A-Award | 3.85 | 2023-03-01 |
| Berman Howard | director, 10 percent owner, officer: Chief Executive Officer | 2023-01-03 | 0 | 2023-01-17 | |
| Berman Howard | officer: Chief Executive Officer | 2023-01-03 | P-Purchase | 0 | 2023-01-04 |
| Berman Howard | officer: Chief Executive Officer | 2023-01-03 | P-Purchase | 0 | 2023-01-04 |
| Lee Ann | director | 2023-01-03 | C-Conversion | 4 | 2023-01-04 |
| Lee Ann | director | 2023-01-03 | P-Purchase | 0 | 2023-01-04 |
| Lee Ann | director | 2023-01-03 | P-Purchase | 0 | 2023-01-04 |
| Lee Ann | director | 2023-01-03 | C-Conversion | 0 | 2023-01-04 |
| Hepner Adrian | officer: Chief Medical Officer | 2023-01-03 | P-Purchase | 0 | 2023-01-04 |
| Hepner Adrian | officer: Chief Medical Officer | 2023-01-03 | P-Purchase | 0 | 2023-01-04 |
| Garren Hideki | director | 2023-01-03 | P-Purchase | 0 | 2023-01-04 |
| Garren Hideki | director | 2023-01-03 | P-Purchase | 0 | 2023-01-04 |
| SNYDER DAVID S | officer: Chief Financial Officer | 2023-01-03 | P-Purchase | 0 | 2023-01-04 |
| SNYDER DAVID S | officer: Chief Financial Officer | 2023-01-03 | P-Purchase | 0 | 2023-01-04 |
| Villalobos Anabella | director | 2023-01-03 | P-Purchase | 0 | 2023-01-04 |
| GOLDSTEIN DOV A MD | director | 2023-01-03 | P-Purchase | 0 | 2023-01-04 |
| GOLDSTEIN DOV A MD | director | 2023-01-03 | P-Purchase | 0 | 2023-01-04 |
| Villalobos Anabella | director | 2023-01-03 | P-Purchase | 0 | 2023-01-04 |
| Bertex LLC | director | 2022-12-28 | 0 | 2022-12-28 | |
| SNYDER DAVID S | officer: Chief Financial Officer | 2022-12-28 | 3.47 | 2022-12-28 | |
| Lee Ann | director | 2022-12-28 | 4 | 2022-12-28 | |
| Garren Hideki | director | 2022-05-01 | 1.09 | 2022-12-28 | |
| Hepner Adrian | officer: Chief Medical Officer | 2022-11-01 | 3.47 | 2022-12-28 | |
| GOLDSTEIN DOV A MD | director | 2021-04-01 | 1.09 | 2022-12-28 | |
| Berman Howard | officer: Chief Executive Officer | 2022-12-28 | 0 | 2022-12-28 | |
| Villalobos Anabella | director | 2021-07-01 | 1.09 | 2022-12-28 |